Copyright Reports & Markets. All rights reserved.

Global Chorea Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Chorea Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Medication
      • 1.4.3 Surgery Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Chorea Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Chorea Treatment Market Size
    • 2.2 Chorea Treatment Growth Trends by Regions
      • 2.2.1 Chorea Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Chorea Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Chorea Treatment Market Size by Manufacturers
      • 3.1.1 Global Chorea Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Chorea Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Chorea Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Chorea Treatment Key Players Head office and Area Served
    • 3.3 Key Players Chorea Treatment Product/Solution/Service
    • 3.4 Date of Enter into Chorea Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Chorea Treatment Market Size by Type (2014-2019)
    • 4.2 Global Chorea Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Chorea Treatment Market Size (2014-2019)
    • 5.2 Chorea Treatment Key Players in United States
    • 5.3 United States Chorea Treatment Market Size by Type
    • 5.4 United States Chorea Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Chorea Treatment Market Size (2014-2019)
    • 6.2 Chorea Treatment Key Players in Europe
    • 6.3 Europe Chorea Treatment Market Size by Type
    • 6.4 Europe Chorea Treatment Market Size by Application

    7 China

    • 7.1 China Chorea Treatment Market Size (2014-2019)
    • 7.2 Chorea Treatment Key Players in China
    • 7.3 China Chorea Treatment Market Size by Type
    • 7.4 China Chorea Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Chorea Treatment Market Size (2014-2019)
    • 8.2 Chorea Treatment Key Players in Japan
    • 8.3 Japan Chorea Treatment Market Size by Type
    • 8.4 Japan Chorea Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Chorea Treatment Market Size (2014-2019)
    • 9.2 Chorea Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Chorea Treatment Market Size by Type
    • 9.4 Southeast Asia Chorea Treatment Market Size by Application

    10 India

    • 10.1 India Chorea Treatment Market Size (2014-2019)
    • 10.2 Chorea Treatment Key Players in India
    • 10.3 India Chorea Treatment Market Size by Type
    • 10.4 India Chorea Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Chorea Treatment Market Size (2014-2019)
    • 11.2 Chorea Treatment Key Players in Central & South America
    • 11.3 Central & South America Chorea Treatment Market Size by Type
    • 11.4 Central & South America Chorea Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Medtronic
      • 12.1.1 Medtronic Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Chorea Treatment Introduction
      • 12.1.4 Medtronic Revenue in Chorea Treatment Business (2014-2019)
      • 12.1.5 Medtronic Recent Development
    • 12.2 Boston Scientific
      • 12.2.1 Boston Scientific Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Chorea Treatment Introduction
      • 12.2.4 Boston Scientific Revenue in Chorea Treatment Business (2014-2019)
      • 12.2.5 Boston Scientific Recent Development
    • 12.3 Aleva Neurotherapeutics
      • 12.3.1 Aleva Neurotherapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Chorea Treatment Introduction
      • 12.3.4 Aleva Neurotherapeutics Revenue in Chorea Treatment Business (2014-2019)
      • 12.3.5 Aleva Neurotherapeutics Recent Development
    • 12.4 Teva Pharmaceutical
      • 12.4.1 Teva Pharmaceutical Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Chorea Treatment Introduction
      • 12.4.4 Teva Pharmaceutical Revenue in Chorea Treatment Business (2014-2019)
      • 12.4.5 Teva Pharmaceutical Recent Development
    • 12.5 Pfizer
      • 12.5.1 Pfizer Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Chorea Treatment Introduction
      • 12.5.4 Pfizer Revenue in Chorea Treatment Business (2014-2019)
      • 12.5.5 Pfizer Recent Development
    • 12.6 GlaxoSmithKline
      • 12.6.1 GlaxoSmithKline Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Chorea Treatment Introduction
      • 12.6.4 GlaxoSmithKline Revenue in Chorea Treatment Business (2014-2019)
      • 12.6.5 GlaxoSmithKline Recent Development
    • 12.7 Bausch Health Companies
      • 12.7.1 Bausch Health Companies Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Chorea Treatment Introduction
      • 12.7.4 Bausch Health Companies Revenue in Chorea Treatment Business (2014-2019)
      • 12.7.5 Bausch Health Companies Recent Development
    • 12.8 LivaNova
      • 12.8.1 LivaNova Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Chorea Treatment Introduction
      • 12.8.4 LivaNova Revenue in Chorea Treatment Business (2014-2019)
      • 12.8.5 LivaNova Recent Development
    • 12.9 Lundbeck
      • 12.9.1 Lundbeck Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Chorea Treatment Introduction
      • 12.9.4 Lundbeck Revenue in Chorea Treatment Business (2014-2019)
      • 12.9.5 Lundbeck Recent Development
    • 12.10 Ipsen
      • 12.10.1 Ipsen Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Chorea Treatment Introduction
      • 12.10.4 Ipsen Revenue in Chorea Treatment Business (2014-2019)
      • 12.10.5 Ipsen Recent Development
    • 12.11 Alnylam Pharmaceuticals
    • 12.12 Prana Biotechnology
    • 12.13 RespireRx Pharmaceuticals
    • 12.14 Vertex Pharmaceuticals
    • 12.15 SOM Biotech

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Chorea is an abnormal involuntary movement characterized by brief, abrupt, unpredictable, irregular, non-stereotyped movements. Chorea may worsen with anxiety and voluntary movements, and subsides during sleep The major causes of chorea include use of oral contraceptives, pregnancy, autoimmune disorders, paraneoplastic syndromes, hyperthyroidism, hypoparathyroidism, and hyperglycemia.
      In 2018, the global Chorea Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Chorea Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chorea Treatment development in United States, Europe and China.

      The key players covered in this study
      Medtronic
      Boston Scientific
      Aleva Neurotherapeutics
      Teva Pharmaceutical
      Pfizer
      GlaxoSmithKline
      Bausch Health Companies
      LivaNova
      Lundbeck
      Ipsen
      Alnylam Pharmaceuticals
      Prana Biotechnology
      RespireRx Pharmaceuticals
      Vertex Pharmaceuticals
      SOM Biotech

      Market segment by Type, the product can be split into
      Medication
      Surgery Therapy

      Market segment by Application, split into
      Hospitals
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Chorea Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Chorea Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Chorea Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now